Public Service Loan Forgiveness Program Has Uncertain Future
Justifiable reasons for supporting and changing program, but not for keeping graduates in suspense
Read More
Author: Janine Anthes
Out-of-Pocket Costs Similar for Infliximab, Infliximab-Dyyb
Mean total costs per eight-week prescription and annually modestly lower for infliximab biosimilar
Read More
Recent Increase in Contraception Use Noted Among U.S. Teenagers
Increases in use of one or more contraceptive methods, dual-method use, long-acting reversibles
Read More
Google Search for Cardiovascular Disease Peaks in Winter
Seasonal patterns of relative search volumes seen for queries relating to cardiovascular disease
Read More
Baloxavir Superior to Placebo for Alleviating Flu Symptoms
Shorter median time to alleviation of symptoms versus placebo; similar alleviation time to oseltamivir
Read More
Heart CTA Results in Lower Death Rate From CHD, Non-Fatal MI
Lower death rate from coronary heart disease, non-fatal MI at 5 yr in patients with stable chest pain
Read More
130 Now Sickened by Salmonella-Tainted Honey Smacks Cereal
Thirty-four people have been hospitalized, but no deaths have been reported
Read MoreAugust 2018 Briefing – Allergy
Here are what the editors at HealthDay consider to be the most important developments in Allergy for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. An Allergy to Red Meat May Be Tied […]
Read MoreAugust 2018 Briefing – Cardiology
Here are what the editors at HealthDay consider to be the most important developments in Cardiology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. An Allergy to Red Meat May Be Tied […]
Read MoreAugust 2018 Briefing – Dermatology
Here are what the editors at HealthDay consider to be the most important developments in Dermatology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Medical Bills in Collections Decrease With Patient Age […]
Read MoreAugust 2018 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Medical Bills in Collections Decrease With […]
Read MoreAugust 2018 Briefing – Family Practice
Here are what the editors at HealthDay consider to be the most important developments in Family Practice for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Helmets May Not Protect Skiers From Traumatic […]
Read MoreAugust 2018 Briefing – Gastroenterology
Here are what the editors at HealthDay consider to be the most important developments in Gastroenterology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by Publix Super Markets […]
Read MoreAugust 2018 Briefing – HIV & AIDS
Here are what the editors at HealthDay consider to be the most important developments in HIV & AIDS for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Medical Bills in Collections Decrease With […]
Read MoreAugust 2018 Briefing – Infectious Disease
Here are what the editors at HealthDay consider to be the most important developments in Infectious Disease for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by Publix Super […]
Read MoreAugust 2018 Briefing – Neurology
Here are what the editors at HealthDay consider to be the most important developments in Neurology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Helmets May Not Protect Skiers From Traumatic Brain […]
Read MoreAugust 2018 Briefing – Nursing
Here are what the editors at HealthDay consider to be the most important developments in Nursing for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by Publix Super Markets […]
Read MoreAugust 2018 Briefing – OBGYN & Women’s Health
Here are what the editors at HealthDay consider to be the most important developments in OBGYN & Women’s Health for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Ground Chuck Products Recalled by […]
Read MoreAugust 2018 Briefing – Hematology & Oncology
Here are what the editors at HealthDay consider to be the most important developments in Hematology & Oncology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Medical Bills in Collections Decrease With […]
Read MoreAugust 2018 Briefing – Ophthalmology
Here are what the editors at HealthDay consider to be the most important developments in Ophthalmology for August 2018. This roundup includes the latest research news from journal articles, as well as the FDA approvals and regulatory changes that are the most likely to affect clinical practice. Medical Bills in Collections Decrease With Patient Age […]
Read More